In an international collaboration, researchers have made an important breakthrough in the therapeutic delivery of microRNAs ...

Working toward more effective tuberculosis (TB) vaccines, researchers at Weill Cornell Medicine have developed two strains of ...

Oncolytics Biotech® Inc. (NASDAQ: ONCY) (TSX: ONC), a leading clinical-stage company specializing in immunotherapy for ...

InflaRx will conduct a virtual fireside chat on March 27 at 8:30 AM ET and will participate in one-on-one-investor meetings. A link to register for the fireside chat live stream and its replay is ...

The FDA accepted for priority review a supplemental Biologics License Application for Keytruda for resectable locally ...

Every year, 900,000 Americans are caught by surprise by the symptoms of a pulmonary embolism: a sudden shortness of breath, ...

Kiniksa’s actions leave it focused on a cardiovascular disease pipeline led by the IL-1 antagonist KPL-387. The program is ...

LUCY Letby’s former boss thought that she was a “scapegoat” for the hospital’s failings and would be cleared without charge, a former chief executive has claimed. Letby, ...

The Pregnancy Meeting researchers will unveil findings from a clinical trial in India that suggest that a single dose of iron delivered intravenously early in the second trimester is a safe and ...

Already having been legalised in many European countries, alongside Canada and several states in the US, assisted dying seems to be slowly becoming a hallmark of the modern medical system. The choice ...

The first hemophilia B patient at the Loma Linda University Health Hemophilia Treatment Center to receive Hympavzi is a ...